Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas

Patient Guideline Summary

Publication Date: February 16, 2022

Last Updated: November 29, 2023

Objective

This patient summary means to discuss key recommendations from the College of American Pathologists in collaboration with the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology for molecular biomarker testing for the diagnosis of diffuse gliomas.